Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma

Clinical Cancer Research

Volumn 4, Issue 6, 1998, Pages 1533-1542

  Dexter, Dwayne W ^a   Reddy, Raju K ^a   Geles, Ken G ^a,b   Bansal, Sudha ^a   Myint, Maung A ^a   Rogakto, Andre ^a   Leighton, John C ^a,c   Goldstein, Lori J ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P;

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; CANCER RESISTANCE; CONTROLLED STUDY; FEMALE; GENE ISOLATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CELL LINE; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM METASTASIS; NEOPLASM STAGING; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGRESSION ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0031778651     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug resistance transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
2. Endicott, J., and Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58: 137-171, 1989.
3. Horio, M., Gottesman, M. M., and Pastan, I. ATP-dependent transport of vinblastine in vesicles from human multidrug resistant cells. Proc. Natl. Acad. Sci. USA, 85: 3580-3584, 1984.
4. Hyde, S. C., Emsley, P., Hartshorn, M. J., Mimmack, M. M., Gileadi, U., Pearce, S. R., Gallagher, M. P., Gill, D. R., Hubbard, R. E., and Higgins, C. F. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature (Lond.), 346: 362-365, 1990.
5. Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S. L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., Lieber, M., Cossman, J., Gottesman, M. M., and Pastan, I. Expression of a human multidrug resistance gene in human cancers. J. Natl. Cancer Inst., 81: 116-124, 1989.
6. Bourhis, J., Benard, J., Hartmann, O., Boccon-Gibod, L., Lemerle, J., and Riou, G. Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J. Natl. Cancer Inst., 81: 1401-1405, 1989.
7. Chan, H. S., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N., Yeger, H., and Ling, V. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl. J. Med., 325: 1608-1614, 1991.
8. Chan, H., Thorner, P. S., Haddad, G., and Ling, V. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J. Clin. Oncol., 8: 689-704, 1990.
9. Holmes, J., Jacobs, A., Carter, G., Janowska-Wieczorek, A., and Padua, R. A. Multidrug resistance in haemopoietic cell lines, myelodysplastic syndrome and acute mybleoblastic leukaemia. Br. J. Haematol., 72: 40-44, 1989.
10. Pirker, R., Wallner, J., Geissler, K., Linkesch, W., Haas, O. A., Bettelheim, P., Hopfner, M., Scherrer, R., Valent, P., Havelec, L., Liselotte, H., Ludwig, H., and Leehner, K. MDR1 gene expression and treatment outcome in acute myeloid leukemia. J. Natl. Cancer Inst., 83: 708-712, 1991.
11. Baldini, N., Scotlandi, K., Barbanti-Brodano, G., Manara, M. C., Maurici, D., Bacci, G., Bertoni, F., Picci, P., Sottili, S., Campanacci, M., and Serra, M. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N. Engl. J. Med., 333: 1380-1385, 1995.
12. Cole, S. P., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M., and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC), 258: 1650-1654, 1992.
13. Krishnamachary, N., and Center, M. S. The MRP gene associated with non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res., 53: 3658-3661, 1993.
14. Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P., and Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural products. Cancer Res., 54: 357-361, 1994.
15. Kruh, G. D, Chan, A., Myers, K., Gaughan, K., Miki, T., and Aaronson, S. A. Expression complementary DNA library transfer establishes MRP as a multidrug resistance gene. Cancer Res., 54: 1649-1652, 1994.
16. Breuninger, L. M., Paul, S., Gaughan, K., Miki, T., Chan, A., Aaronson, S. A., and Kruh, G. D. Expression of multidrug resistance-associated protein in NIH/3T3 cell confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res., 55: 5342-5347, 1995.
17. Zaman, G. J., Lankelma, J., van Tellingen, O., Beijnen, J., Dekker, H., Paulusma, C., Oude Elferink, R. P., Baas, F., and Borst, P. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc. Natl. Acad. Sci. USA, 92: 7690-7694, 1995.
18. Cole, S. P., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54: 5902-5910, 1994.
19. Flens, M. J., Zaman, G. J., van der Valk, P., Izquierdo, M. A., Schroeijers, A. B., Scheffer, G. L., van der Groep, P., de Haas, M., Meijer, C. J., and Scheper, R. J. Tissue distribution of the multidrug resistance protein. Am. J. Pathol., 148: 1237-1247, 1996.
20. Zaman, G. J., Versantvoort, C. H., Smit, J. J., Eijdems, E. W., de Haas, M., Smith, A. J., Broxterman, H. J., Mulder, N. H., de Vries, E. G., Baas, F., and Borst, P. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidurg resistant lung cancer cell lines. Cancer Res., 53: 1747-1750, 1993.
21. Kruh, G. D., Gaughan, K. T., Godwin, A., and Chan, A. Expression pattern of MRP in human tissues and adult solid tumor cell lines. J. Natl. Cancer Inst., 87: 1256-1258, 1995.
22. Nooter, K., Westerman, A. M., Flens, M. J., Zaman, G. J. R., Scheper, R. J., van Wingerden, K. E., Burger, H., Oostrum, R., Boersma, T., Sonneveld, P., Grataman, J. W., Kok, T., Eggermont, A. M. M., Bosman, F. T., and Stoter, G. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin. Cancer Res., 1: 1301-1310, 1995.
23. Campling, B. G., Young, L. C., Baer, K. A., Lam, Y. M., Deeley, R. G., Cole, S. P. C., and Gerlach, J. H. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer. Clin. Cancer Res., 3: 115-122, 1997.
24. Shen, D. W., Cardarelli, C., Hwang, J., Cornwall, M., Richert, N., Ishii, S., Pastan, I., and Gottesman, M. M. Multiple drug resistant human KB carcinoma cells independently selected for high level resistance to colchicine, Adriamycin or vinblastine show changes in expression of specific proteins. J. Biol. Chem., 267: 7762-7770, 1986.
25. Fairchild, C. R., Ivy, S. P., Kao-Shan, C. S., Whang-Peng, J., Rosen, N., Israel, M. A., Melera, P. W., Cowan, K. H., and Goldsmith, M. E. Isolation of amplified and overexpressed DNA sequences from Adriamycin-resistant human breast carcinoma cells. Cancer Res., 47: 5141-5148, 1987.
26. Schneider, E., Horton, J. K., Yang, C-H., Nakagawa, M., and Cowan, K. H. Multidrug resistance-associated protein overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MDF7 cell line selected for etoposide resistance. Cancer Res., 54: 152-158, 1994.
27. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
28. Becker-Andre, M., and Hahlbrock, K. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by PCR aided transcript titration assay (PATTY). Nucleic Acids Res., 17: 9437-9446, 1989.
29. Zacher, V., Thomas, R. A., and Goustin, A. S. Absolute quantification of target DNA: a simple competitive PCR for efficient analysis of multiple samples. Nucleic Acids Res., 21: 2017-2018, 1993.
30. Mechetner, E., Kyshtoobayeva, A., Zonis, S., Kim, H., Stroup, R., Garcia, R., Parker, R. J., and Fruehof, J. P. Levels of MDR1 P-glycoprotein expression by human breast cancer correlate with in vitro resistance to Taxol and doxorubicin. Clin. Cancer Res., 4: 389-398, 1998.
31. Clifford, S. C., Neal, D. E., and Lunec, J. Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder. Br. J. Cancer, 73: 659-666, 1996.
32. Beck, W. T., Grogan, T. M., Willman, C. L., Cordon-Cardo, C., Parham, D. M., Kuttesch, J. F., Andreff, M., Bates, S. E., Berard, C. W., Boyett, J. M., Brophy, N. A., Broxterman, H. J., Chan, H. S. L., Dalton, W. S., Dietel, M., Fojo, A. T., Gascoyne, R. D., Head, D., Houghton, P. J., Srivastava, D. K., Lehnen, M., Leith, C. P., Paietta, E., Pavelic, Z. P., Rimsza, L., Roninson, I. B., Sikic, B. I., Twentyman, P. R., Warnke, R., and Weinstein, R. Methods to detect P-glycoprotein-associated multidrug resistance in patients tumors: consensus recommendations. Cancer Res., 56: 310-3120, 1996.
33. Noonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D., and Roninson, I. B. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 87: 7160-7164, 1990.
34. Murphy, L. D., Herzog, C. E., Rudick, J. B., Fojo, A. T., and Bates, S. E. Use of the polymerase chain reaction in the quantitation of mdr1 gene expression. Biochemistry, 196: 161-169, 1990.
35. Futscher, B. W., Blake, L. L., Gerlach, J. H., Grogan, T. M., and Dalton, W. S. Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens. Anal. Biochem., 213: 414-421, 1993.
36. Deburie, B., Sol, O., Lemoine, A., and May, E. Nonisotopic competitive RT-PCR assay to measure MDR1 gene expression. Mol. Pathol., 41: 819-825, 1995.
37. Filipitis, M., Suchomel, R. W., Dekan, G., Haider, K., Valdimarsson, G., Depishch, D., and Pirker, R. MRP and MDR1 gene expression in primary breast carcinomas. Clin Cancer Res., 2: 1231-1237, 1996.
38. Trock, B. J., Leonessa, F., and Clarke, R. Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. J. Natl. Cancer Inst., 89: 917-931, 1997.
39. Clark, G. M. Prognostic and predictive factors. In: J. R. Harris, M. E. Lippman, M. Morrow, and S. Hellman (eds.), Diseases of the Breast, pp 461-485. Philadelphia: Lippincott-Raven, 1996.
40. Wishart, G. C., Plumb, J. A., Going, J. J., McNicol, A. M., McArdle, C. S., and Tsuruo, T. P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br. J. Cancer, 62: 758-761, 1990.
41. Thiebaut, F., Tsurou, T., Hamada, H., Gottesman, M. M., Pastan, I., and Willingham, M. C. Immunohistochemical localisation in normal tissue of different epitopes in multidrug transport protein P170: evidence of localisation in brain capillaries and cross-reactivity of one antibody with muscle protein. J. Histochem. Cytochem., 37: 159-164, 1989.
42. Liu, B., Sun, D., Xia, W., Hung, M. C., and Yu, D. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erB2) in breast cancer cells: cautions on evaluating p170-(mdr-1). J. Natl. Cancer Inst., 89: 1524-1529, 1997.
43. Charpin, C., Vielh, P., Duffard, F., Devictor, B., Andrac, L., Lavaut, M. N., Allasia, C., Horschowski, N., and Piana, L. Quantitative immunohistochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators. J. Natl. Cancer Inst., 86: 1539-1545, 1994.
44. Scneider, J., Rubio, M-P., Barbazan, M-J., Rodriquez-Escudero, F. J., Seizinger, B. R., and Castresana, J. S. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors. J. Natl. Cancer Inst., 86: 850-855, 1994.
45. Linn, S. C., Honkoop, A. H., Hoekman, K., van der Valk, P., Pinedo, H. M., and Giaccone, G. p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. Br. J. Cancer., 74: 63-68, 1996.
46. Salmon, S. E., Grogan, T. M., Miller, T. Scheper, R., and Dalton, W. S. Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining. J. Natl. Cancer Inst., 81: 696-701, 1989.
47. Wang, C. S., LaRue, H., Fortin, A., Gariepy, G., and Tetu, B. mdr1 mRNA expression by RT-PCR in patients with primary breast carcinoma submitted to neoadjuvant therapy. Breast Cancer Res. Treat., 45: 63-74, 1997.
48. Koh, E. H., Chung, H. C., Lee, K. B., Lim, H. Y., Kim, J. H., Roh, J. K., Min, J. S., Lee, K. S., and Kim, B. S. The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy. Yonsei Med. J., 33: 137-142, 1992.
49. Yang, X., Uziely, B., Groshen, S., Lukas, J., Israel, V., Russell, C., Dunnington, G., Formenti, S., Muggis, F., and Press, M. F. MDR1 gene expression in primary and advanced breast cancer. Proc. Am. Assoc. Cancer Res., 38: #2610, 1997.
50. Ota, E., Abe, Y., Oshika, Y., Ozeki, Y., Iwasaki, M., Inoue, H., Yamazaki, H., Ueyama, Y., Takagi, K., Ogata, T., Tamaoki, N., and Nakamura, M. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br. J. Cancer, 72: 550-554, 1995.
51. Bordow, S. B., Haber, M., Madafiglio, J., Cheung, B., Marshall, G. M., and Norris, M. D. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the n-myc oncogene in childhood neuroblastoma. Cancer Res., 54: 5036-5040, 1994.
52. Kuss, B. J., Deeley, R. G., Cole, S. P., Willman, C. L., Kopecky, K. J., Wolman, S. R., Eyre, H. J., Lane, S. A, Nancarrow, J. K., Whitmore, S. A., and Callan, D. F. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet, 343: 1531-1534, 1994.
53. Filipitis, M., Suchomel, R. W., Dekan, G., Stiglbauer, W., Haider, K., Depisch, D., and Pirker, R. Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas. Br. J. Cancer, 75: 208-212, 1997.
54. Chaudhary, P. M., and Roninson, I. B. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst., 85: 632-639, 1993.
55. Brock, I., Hipfner, D. R., Nielsen, B. S., Jensen, P. B., Deeley, R. G., Cole, S. P., and Sehested, M. Sequential coexpression of the multidrug resistance genes MRP and mdrl and their products in VP-16 (etoposide)-selected H69 small cell lung cancer lines. Cancer Res., 55: 459-462, 1995.